Identification of a novel potent CDK inhibitor degrading cyclinK with a superb activity to reverse trastuzumab-resistance in HER2-positive breast cancer in vivo
Article in European Journal of Medicinal Chemistry (December 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in European Journal of Medicinal Chemistry (December 2023)